Dataset
Gliclazide; LC-ESI-QFT; MS2; CE: 120%; R=15000; [M-H]-
Chemical Information
| InChI | InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19) |
|---|---|
| SMILES | CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 |
| InChI Key | BOVGTQGAOIONJV-UHFFFAOYSA-N |
| Molecular Formula | C15H21N3O3S |
| Exact Mass | 323.130 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-sa/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ01102257 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2024-06-14 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| PD001261 | ProbesDrugs |
| LSM-5096 | LINCS |
| 21187-98-4 | ACToR |
| 14826273 | PubChem: Thomson Pharma |
| gliclazide-diamicron | Selleck |
| SCHEMBL16387 | SureChEMBL |
| 538655 | eMolecules |
| MCULE-7993816491 | Mcule |
| 3475 | PubChem |
| HMDB0015252 | Human Metabolome Database |
| PA10892 | PharmGKB |
| CB5113462 | ChemicalBook |
| CHEMBL427216 | ChEMBL |
| 31654 | ChEBI |
| J3.151H | Nikkaji |
| 1299 | DrugCentral |
| DTXSID9023095 | EPA CompTox Dashboard |
| HY-B0753 | MedChemExpress |
| S-852 | clinicaltrials |
| DIAMICRON | clinicaltrials |
| GLICLAZIDE | clinicaltrials |
| S-1702 | clinicaltrials |
| GLICLAZIDE | rxnorm |
| CB71176349 | ChemicalBook |
| 50103512 | BindingDB |
| The data in this table is sourced from UniChem at EBI. | |